TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ARQT

Arcutis Biotherapeutics Inc

Healthcare · Biotechnology

26.50$ +1.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Arcutis Biotherapeutics Inc (ARQT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 489 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARQT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
293 341 479 445 437 349 344 352 371 433 460 489
282 330 468 435 424 336 324 333 349 411 438 468
107 88 191 85 135 71 53 73 47 43 35 34
227 272 404 363 331 228 198 191 191 221 224 239
19 26 37 43 60 73 85 107 115 146 144 155
14 13 13 14 14 15 17 16 22 23 37 39
6.6 6.4 6.3 6.1 9.8 9.5 17 16 15 15 14 14
246 253 254 258 281 191 201 213 213 243 270 268
42 47 47 51 172 81 91 104 100 130 163 160
0.7 0.7 0.8 0.8 100 0.8 0.8 1.0 1.0 1.0 8.0 7.0
13 12 13 7.9 19 14 25 15 5.8 13 18 6.6
201 202 203 204 105 107 108 107 107 108 101 102
47 89 225 186 157 158 143 139 158 189 190 221
-916 -982 -1,017 -1,070 -1,111 -1,122 -1,147 -1,163 -1,155 -1,138 -1,149 -1,134
62 93 111 123 124 121 126 127 133 136 129 136

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?